Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Daniel R. Greenwald"'
Autor:
Loretta J. Nastoupil, John Kuruvilla, Julio C. Chavez, Fontanet Bijou, Thomas E. Witzig, Armando Santoro, Ian W. Flinn, Carola Boccomini, Vaishalee P. Kenkre, Paolo Corradini, Iris Isufi, David J. Andorsky, Leonard M. Klein, Daniel R. Greenwald, Randeep Sangha, Frank Shen, Patrick Hagner, Yan Li, Juergen Dobmeyer, Nian Gong, Shailaja Uttamsingh, Michael Pourdehnad, Vincent Ribrag
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 394-405 (2022)
Abstract The multicenter, phase Ib CC‐122‐DLBCL‐001 dose‐expansion study (NCT02031419) explored the cereblon E3 ligase modulator (CELMoD) agent avadomide (CC‐122) plus rituximab in patients with relapsed/refractory (R/R) diffuse large B‐c
Externí odkaz:
https://doaj.org/article/893d9f4d49df48ae90782ee3c1a4ed6c
Autor:
Anda Gershon, Esprit Ma, Tao Xu, Melissa Montez, Kiran Naqvi, Grace Ku, Wendy Wei-Han Cheng, Evelyn M. Flahavan, Vamsi Kota, Daniel R. Greenwald
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:e222-e231
Autor:
J. Randolph Hecht, Scott Kopetz, Theodore Welling, Maria Pia Morelli, Julian R. Molina, Kedar Kirtane, Paul Eliezer Oberstein, Daniel R. Greenwald, Yi Lin, Armen Mardiros, Karl Beutner, Ariane Lozac'hmeur, Ameen Salahudeen, Kirstin B. Liechty, Judy Vong, Eric Wai-Choi Ng, David G. Maloney, William Y. Go, John Sutton Welch, Diane M. Simeone
Publikováno v:
Journal of Clinical Oncology. 41:209-209
209 Background: Metastatic colorectal (CRC), pancreatic (PANC), and gastroesophageal cancers are the leading causes of GI cancer–related mortality (5-y survival: 15%, 3%, and 5%-6%, respectively) (ACS 2022). HLA LOH is a recurrent mechanism of immu
Autor:
M.C. Liu, G.R. Oxnard, E.A. Klein, C. Swanton, M.V. Seiden, Minetta C. Liu, Geoffrey R. Oxnard, Eric A. Klein, David Smith, Donald Richards, Timothy J. Yeatman, Allen L. Cohn, Rosanna Lapham, Jessica Clement, Alexander S. Parker, Mohan K. Tummala, Kristi McIntyre, Mikkael A. Sekeres, Alan H. Bryce, Robert Siegel, Xuezhong Wang, David P. Cosgrove, Nadeem R. Abu-Rustum, Jonathan Trent, David D. Thiel, Carlos Becerra, Manish Agrawal, Lawrence E. Garbo, Jeffrey K. Giguere, Ross M. Michels, Ronald P. Harris, Stephen L. Richey, Timothy A. McCarthy, David M. Waterhouse, Fergus J. Couch, Sharon T. Wilks, Amy K. Krie, Rama Balaraman, Alvaro Restrepo, Michael W. Meshad, Kimberly Rieger-Christ, Travis Sullivan, Christine M. Lee, Daniel R. Greenwald, William Oh, Che-Kai Tsao, Neil Fleshner, Hagen F. Kennecke, Maged F. Khalil, David R. Spigel, Atisha P. Manhas, Brian K. Ulrich, Philip A. Kovoor, Christopher Stokoe, Jay G. Courtright, Habte A. Yimer, Timothy G. Larson, Charles Swanton, Michael V. Seiden, Steven R. Cummings, Farnaz Absalan, Gregory Alexander, Brian Allen, Hamed Amini, Alexander M. Aravanis, Siddhartha Bagaria, Leila Bazargan, John F. Beausang, Jennifer Berman, Craig Betts, Alexander Blocker, Joerg Bredno, Robert Calef, Gordon Cann, Jeremy Carter, Christopher Chang, Hemanshi Chawla, Xiaoji Chen, Tom C. Chien, Daniel Civello, Konstantin Davydov, Vasiliki Demas, Mohini Desai, Zhao Dong, Saniya Fayzullina, Alexander P. Fields, Darya Filippova, Peter Freese, Eric T. Fung, Sante Gnerre, Samuel Gross, Meredith Halks-Miller, Megan P. Hall, Anne-Renee Hartman, Chenlu Hou, Earl Hubbell, Nathan Hunkapiller, Karthik Jagadeesh, Arash Jamshidi, Roger Jiang, Byoungsok Jung, TaeHyung Kim, Richard D. Klausner, Kathryn N. Kurtzman, Mark Lee, Wendy Lin, Jafi Lipson, Hai Liu, Qinwen Liu, Margarita Lopatin, Tara Maddala, M. Cyrus Maher, Collin Melton, Andrea Mich, Shivani Nautiyal, Jonathan Newman, Joshua Newman, Virgil Nicula, Cosmos Nicolaou, Ongjen Nikolic, Wenying Pan, Shilpen Patel, Sarah A. Prins, Richard Rava, Neda Ronaghi, Onur Sakarya, Ravi Vijaya Satya, Jan Schellenberger, Eric Scott, Amy J. Sehnert, Rita Shaknovich, Avinash Shanmugam, K.C. Shashidhar, Ling Shen, Archana Shenoy, Seyedmehdi Shojaee, Pranav Singh, Kristan K. Steffen, Susan Tang, Jonathan M. Toung, Anton Valouev, Oliver Venn, Richard T. Williams, Tony Wu, Hui H. Xu, Christopher Yakym, Xiao Yang, Jessica Yecies, Alexander S. Yip, Jack Youngren, Jeanne Yue, Jingyang Zhang, Lily Zhang, Lori (Quan) Zhang, Nan Zhang, Christina Curtis, Donald A. Berry
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology
Background Early cancer detection could identify tumors at a time when outcomes are superior and treatment is less morbid. This prospective case-control sub-study (from NCT02889978 and NCT03085888) assessed the performance of targeted methylation ana
Autor:
Leonard M. Klein, Daruka Mahadevan, Suzanne R. Fanning, Hari P. Miskin, Daniel R. Greenwald, Michael S. Weiss, Heather D. Brooks, Peter Sportelli, Kathryn S. Kolibaba, Charles M. Farber, Jeff P. Sharman, John M. Burke, Marshall T. Schreeder
Publikováno v:
British journal of haematology. 176(3)
Summary Ibrutinib is effective in patients with chronic lymphocytic leukaemia (CLL); however, treatment resistance remains a problem. Ublituximab is a novel, glycoengineered anti-CD20 monoclonal antibody with single-agent activity in relapsed CLL. We
Autor:
Erkki Ruoslahti, Lilach Agemy, Venkata Ramana Kotamraju, Tambet Teesalu, Priya Prakash Karmali, Kazuki N. Sugahara, Daniel R. Greenwald
Publikováno v:
Science. 328:1031-1035
Penetrating Attack on Tumors While considerable research effort in oncology is focused on the design of new cancer drugs, an important but relatively understudied research area is the development of methods that optimize the delivery and tumor penetr
Publikováno v:
Annual Review of Biophysics and Biomolecular Structure. 27:165-198
▪ Abstract Identification of biomolecules in complex biological mixtures represents a major challenge in biomedical, environmental, and chemical research today. Chemical separations with traditional detection schemes such as absorption, fluorescenc
Autor:
Randy D. Gascoyne, Selina M. Luger, Ronald S. Go, Brad S. Kahl, Daniel R. Greenwald, David King, Taral Patel, Jill M. Kolesar, Hailun Li, Sandra J. Horning
Publikováno v:
Journal of Hematology & Oncology
Patients with diffuse large B cell lymphoma (DLBCL) who are not candidates for or recur after autologous stem cell transplant have a poor overall prognosis. We conducted a phase II study of sorafenib (formerly BAY 43–9006) in the treatment of relap
Autor:
Javier F. Torres-Roca, James W. Tung, Daniel R. Greenwald, J. Martin Brown, Leonore A. Herzenberg, Leonard A. Herzenberg, Peter D. Katsikis
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 165(9)
The roles of oxygen and reactive oxygen intermediates in apoptosis are unclear at present. Although oxygen and reactive oxygen intermediates are not required for the execution of apoptosis, oxygen may be involved in at least some forms of apoptosis.